Caricamento...
Evolving Personalized Therapy for Castration-Resistant Prostate Cancer
With advances in molecular biologic and genomic technology, detailed molecular mechanisms for development of castration-resistant prostate cancer (CRPC) have surfaced. Metastatic prostate cancer (PCa) no longer represents an end stage, with many emerging therapeutic agents approved as effective in p...
Salvato in:
| Pubblicato in: | Biomedicine (Taipei) |
|---|---|
| Autori principali: | , , , , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
China Medical University
2014
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4264971/ https://ncbi.nlm.nih.gov/pubmed/25520915 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7603/s40681-014-0002-5 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|